NAYA Biosciences Inc. Com...

NASDAQ: IVF · Real-Time Price · USD
1.56
-0.19 (-10.86%)
At close: Aug 15, 2025, 3:59 PM
1.58
1.28%
After-hours: Aug 15, 2025, 05:45 PM EDT

NAYA Biosciences Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
741.4K 232.42K 90.14K 5.68M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
740.76K 3.09M 1.24M 1.49M
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
174.88K 140.55K 77.15K 50.47K
Inventory
219.76K 264.51K 263.6K 287.77K
Other Current Assets
182.29K 622.29K 190.2K n/a
Total Current Assets
1.32M 1.26M 621.09K 6.31M
Property-Plant & Equipment
2.75M 4.19M 1.85M 2.54M
Goodwill & Intangibles
41.64M 9.97M n/a 132.09K
Total Long-Term Assets
45.13M 17.25M 3.09M 4.16M
Total Assets
46.45M 18.51M 3.71M 10.47M
Account Payables
5.71M 2.33M 1.35M 443.42K
Deferred Revenue
602.36K 408.77K 119.88K 5.9K
Short-Term Debt
6.34M 1.51M 762.64K n/a
Other Current Liabilities
2.53M 1.07M 946.26K 581.69K
Total Current Liabilities
17.93M 8M 3.34M 1.25M
Long-Term Debt
1.13M 1.25M n/a n/a
Other Long-Term Liabilities
12.46M 5M n/a n/a
Total Long-Term Liabilities
15.78M 9.61M 1.35M 1.9M
Total Liabilities
33.7M 17.61M 4.69M 3.16M
Total Debt
9.9M 6.3M 2.27M 2.12M
Common Stock
37.00 20.00 61.00 1.19K
Retained Earnings
-67.16M -57.82M -49.78M -38.89M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
12.75M 892.6K -977.61K 7.31M
Total Investments
740.76K 3.09M 1.24M 1.49M